oxaprozin has been researched along with Cardiac Failure in 2 studies
Oxaprozin: An oxazole-propionic acid derivative, cyclooxygenase inhibitor, and non-steroidal anti-inflammatory drug that is used in the treatment of pain and inflammation associated with of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; and ARTHRITIS, JUVENILE.
oxaprozin : A monocarboxylic acid that is a propionic acid derivative having a 4,5-diphenyl-1,3-oxazol-2-yl substituent at position 3. It is non-steroidal anti-inflammatory drug commonly used to relieve the pain and inflammatory responses associated with osteoarthritis and rheumatoid arthritis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "12 patients aged 26-71 years with stable, compensated congestive heart failure (CHF) and 12 healthy controls matched for age, sex, height, weight, and serum albumin, received a 1200-mg oral dose of the nonsteroidal antiinflammatory agent 4,5-diphenyl-2-oxazolepropionic acid (oxaprozin)." | 7.67 | Oxaprozin pharmacokinetics in patients with congestive heart failure. ( Greenblatt, DJ; Knüchel, M; Ochs, HR, 1986) |
| "12 patients aged 26-71 years with stable, compensated congestive heart failure (CHF) and 12 healthy controls matched for age, sex, height, weight, and serum albumin, received a 1200-mg oral dose of the nonsteroidal antiinflammatory agent 4,5-diphenyl-2-oxazolepropionic acid (oxaprozin)." | 3.67 | Oxaprozin pharmacokinetics in patients with congestive heart failure. ( Greenblatt, DJ; Knüchel, M; Ochs, HR, 1986) |
| "Oxaprozin is a nonsteroidal anti-inflammatory drug which reaches peak plasma concentrations 2 to 6 hours after oral administration." | 2.40 | Clinical pharmacokinetics of oxaprozin. ( Davies, NM, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davies, NM | 1 |
| Ochs, HR | 1 |
| Greenblatt, DJ | 1 |
| Knüchel, M | 1 |
1 review available for oxaprozin and Cardiac Failure
| Article | Year |
|---|---|
Clinical pharmacokinetics of oxaprozin.
Topics: Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Drug Interac | 1998 |
1 other study available for oxaprozin and Cardiac Failure
| Article | Year |
|---|---|
Oxaprozin pharmacokinetics in patients with congestive heart failure.
Topics: Adult; Aged; Female; Heart Failure; Humans; Kinetics; Male; Middle Aged; Oxaprozin; Propionates | 1986 |